# Training Grant In Tumor Biology

> **NIH NIH T32** · GEORGETOWN UNIVERSITY · 2021 · $486,639

## Abstract

ABSTRACT: This application seeks renewal of T32 funding for the Tumor Biology Training Program (TBTP).
TBTP is the premier graduate and postdoctoral training program at Georgetown University Medical Center
(GUMC). TBTP is also the only NCI-funded training grant at Georgetown University (GU) and is the only GU
training program dedicated to cancer research. In its 22 year history, the TBTP program has trained hundreds
of young scientists, including many URM scientists, who have gone onto successful cancer–related careers in
academia, industry and education. The mission of the TBTP is to provide trainees with a strong foundation in
translational cancer research that will be required to eradicate human cancer. The program allows trainees to
develop lifelong multidisciplinary skills that will enable them to make significant contributions in the eradication
of human cancer and to fill a training need i.e. to interact productively in their future careers as collaborators with
clinical research and population science programs. The scientist and physician mentors of TBTP are all drawn
from the four integrated Lombardi NCI-designated Comprehensive Cancer Center (LCCC) programs. The
mentors and trainees are focused on 1) understanding basic biological processes that drive initiation and
progression of human cancer, 2) identifying critical targets for the development of novel therapeutics and
therapeutic combinations and to enable monitoring of therapeutic response and development of resistance in
patients, and 3) integrating the knowledge gained from research to the understanding of the prevention and
control of human cancer. LCCC provides the foundation for the TBTP program, stimulating interdisciplinary
collaborations and co-mentoring opportunities, as well as providing translational opportunities through an
expanding clinical research initiative. In this application for renewal, we show how our program will evolve to
meet the changing focus of translational cancer research by exposing trainees to a breadth of basic, clinical and
population science research. Going forward we will challenge ourselves to 1) add additional new and invigorated
training and career development opportunities for our trainees and 2) incorporate translational themes, with
physician input, in all aspects of training consistent with the NCI mission of “supporting cancer research across
the nation to advance scientific knowledge and help all people live longer, healthier lives.”

## Key facts

- **NIH application ID:** 10247007
- **Project number:** 5T32CA009686-25
- **Recipient organization:** GEORGETOWN UNIVERSITY
- **Principal Investigator:** ANNA Tate RIEGEL
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $486,639
- **Award type:** 5
- **Project period:** 1996-07-01 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10247007

## Citation

> US National Institutes of Health, RePORTER application 10247007, Training Grant In Tumor Biology (5T32CA009686-25). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10247007. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*